Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany · Delayed Price · Currency is EUR 337.45
+2.60 (0.78%)
Sep 12, 2025, 5:35 PM CET
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €86.31 billion as of September 12, 2025. Its market cap has decreased by -22.26% in one year.
Market Cap
86.31B
Enterprise Value
77.35B
Revenue
9.72B
Ranking
n/a
PE Ratio
27.87
Stock Price
€337.45
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 86.31B, an increase of 116,725.40%. That is a compound annual growth rate of 22.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 12, 2025 | 86.31B | -13.83% |
| Dec 31, 2024 | 100.17B | 5.60% |
| Dec 29, 2023 | 94.86B | 36.76% |
| Dec 30, 2022 | 69.36B | 41.28% |
| Dec 31, 2021 | 49.09B | -2.28% |
| Dec 31, 2020 | 50.24B | 0.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Siemens Healthineers AG | 52.61B |
| Merck KGaA | 47.56B |
| Bayer Aktiengesellschaft | 27.74B |
| Fresenius SE & Co. KGaA | 26.61B |
| Sartorius Aktiengesellschaft | 12.55B |
| Fresenius Medical Care AG | 12.48B |
| Fielmann Group AG | 4.64B |
| Carl Zeiss Meditec AG | 3.59B |